William Goolsbee

Direktor/Vorstandsmitglied bei HELIX BIOMEDIX, INC.

70 Jahre

Health Technology

Consumer Services

Aktive Positionen von William Goolsbee

Unternehmen	Position	Beginn	Ende
HELIX BIOMEDIX, INC.	Direktor/Vorstandsmitglied	01.01.2019	-
HELIX BIOMEDIX, INC.	Independent Dir/Board Member	01.01.2019	-
BMG Hematology LLC	Vorstandsvorsitzender	-	-
BMG Hematology LLC	Vorsitzender	-	-

Unternehmen	Position	Beginn	Ende
PERCHERON THERAPEUTICS LIMITED	Direktor/Vorstandsmitglied	15.10.2015	15.12.2021
PERCHERON THERAPEUTICS LIMITED	Independent Dir/Board Member	15.10.2015	15.12.2021
SAREPTA THERAPEUTICS, INC.	Direktor/Vorstandsmitglied	30.07.2014	01.01.2016
	Vorsitzender	30.10.2007	30.07.2014
	Independent Dir/Board Member	30.10.2007	01.01.2016
Metrodora Therapeutics, Inc.	Vorsitzender	-	01.01.2015
BMG Pharma LLC	Vorsitzender	01.01.2006	01.01.2011
Horizon Medical, Inc.	Vorstandsvorsitzender	01.01.1987	01.01.2002
	Vorsitzender	01.01.2002	01.01.2002
	Gründer	01.01.1987	01.01.2002
Immunotherapy Corp. Immunotherapy Corp. Pharmaceuticals: OtherHealth Technology Part of Sarepta Therapeutics, Inc., Immunotherapy Corp. develops cancer treatments. The company is based in Seattle, WA. The CEO of the company is Amnon Gonenne. Immunotherapy was acquired by AntiVirals, Inc. on November 06, 1997 for $24 million.	Direktor/Vorstandsmitglied	01.01.1993	01.01.1995
	Vorsitzender	01.01.1995	01.01.1998

University of California, Santa Barbara

Undergraduate Degree

International

Vereinigte Staaten	9
Australien	2

Operativ

Chairman	6
Director/Board Member	4
Independent Dir/Board Member	3

Sektoral

Health Technology	6
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
SAREPTA THERAPEUTICS, INC.	Health Technology
PERCHERON THERAPEUTICS LIMITED	Health Technology
HELIX BIOMEDIX, INC.	Health Technology

Private Unternehmen	5
Immunotherapy Corp. Immunotherapy Corp. Pharmaceuticals: OtherHealth Technology Part of Sarepta Therapeutics, Inc., Immunotherapy Corp. develops cancer treatments. The company is based in Seattle, WA. The CEO of the company is Amnon Gonenne. Immunotherapy was acquired by AntiVirals, Inc. on November 06, 1997 for $24 million.	Health Technology
BMG Pharma LLC
Horizon Medical, Inc.	Health Technology
BMG Hematology LLC
Metrodora Therapeutics, Inc.